Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-02-26 @ 12:38 AM
Study NCT ID:
NCT01678820
Status:
TERMINATED
Last Update Posted:
2018-08-24
First Post:
2012-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2013-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-31
First Submit QC Date:
None
Study First Post Date:
2012-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-16
Results First Submit QC Date:
None
Results First Post Date:
2014-10-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-25
Last Update Post Date:
2018-08-24
Last Update Post Date Type:
ACTUAL